| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.72B | 2.98B | 3.79B | 5.24B | 3.98B | 2.39B |
| Gross Profit | 760.54M | 919.38M | 1.25B | 1.72B | 1.31B | 791.78M |
| EBITDA | -105.30M | 71.11M | 499.36M | 784.21M | 581.70M | 243.45M |
| Net Income | -275.54M | -146.98M | 210.68M | 444.05M | 327.39M | 70.67M |
Balance Sheet | ||||||
| Total Assets | 2.14B | 2.42B | 2.92B | 2.89B | 3.13B | 2.35B |
| Cash, Cash Equivalents and Short-Term Investments | 52.64M | 10.65M | 32.94M | 64.52M | 180.93M | 29.21M |
| Total Debt | 884.90M | 1.10B | 1.35B | 860.96M | 867.07M | 955.48M |
| Total Liabilities | 1.49B | 1.71B | 2.09B | 1.84B | 1.97B | 1.53B |
| Stockholders Equity | 644.41M | 706.62M | 831.26M | 1.04B | 1.16B | 819.68M |
Cash Flow | ||||||
| Free Cash Flow | 222.80M | 239.53M | 266.78M | 572.81M | 251.69M | 217.72M |
| Operating Cash Flow | 266.70M | 320.42M | 372.17M | 653.73M | 305.36M | 256.83M |
| Investing Cash Flow | -1.85M | -79.94M | -412.49M | -170.71M | -107.40M | -538.17M |
| Financing Cash Flow | -292.55M | -259.45M | 10.73M | -591.87M | -34.90M | 211.49M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | $1.36B | 35.95 | 8.07% | ― | 6.26% | -19.33% | |
62 Neutral | $1.43B | 153.74 | 1.29% | ― | 68.17% | -85.42% | |
58 Neutral | $1.79B | 24.33 | ― | ― | 15.48% | ― | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
50 Neutral | $588.11M | -2.19 | -35.90% | ― | -11.42% | -617.31% | |
48 Neutral | $269.94M | -17.41 | -3.76% | ― | -22.14% | -787.87% |
On December 11, 2025, AMN Healthcare Services‘ Board of Directors approved new by-laws to align with Delaware law, revise procedural mechanics for stockholder meetings, and update director nomination processes. These changes, effective immediately, aim to enhance governance and operational efficiency, impacting how stockholder meetings and director nominations are conducted.
The most recent analyst rating on (AMN) stock is a Hold with a $16.50 price target. To see the full list of analyst forecasts on AMN Healthcare Services stock, see the AMN Stock Forecast page.